Name | Value |
---|---|
Revenues | 633.1M |
Cost of Revenue | 303.2M |
Gross Profit | 329.9M |
Operating Expense | 323.6M |
Operating I/L | 6.3M |
Other Income/Expense | -12.8M |
Interest Income | 0.0M |
Pretax | -1,166.1M |
Income Tax Expense | -14.5M |
Net Income/Loss | -1,151.6M |
Envista Holdings Corporation develops, sells, and markets dental products globally. The company operates in two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, prosthetics, orthodontic products, and software packages. The Equipment & Consumables segment provides dental equipment, digital imaging systems, endodontic systems, restorative materials, and infection prevention products. Envista generates revenue by selling these products to oral surgeons, prosthodontists, periodontists, dental offices, clinics, and hospitals under various well-known brands such as Nobel Biocare, Implant Direct, Orascoptic, Dexis, and Gendex.